Targeting MCL-1 in cancer: promise, pitfalls, and the path forward
The current clinical trial evaluating the MCL-1 inhibitor (MCL-1i) S64315 represents an important step in translating preclinical findings into the clinic [1]. While MCL-1 inhibition showed strong ...
Authors
- Varsha Gandhi (ORCID: https://orcid.org/0000-0002-3172-9166)
- Natalia Timofeeva (ORCID: https://orcid.org/0000-0002-6985-3509)
- Aloke Sarkar (ORCID: https://orcid.org/0000-0001-6257-4200)
Institutions
- The University of Texas MD Anderson Cancer Center (US)
Publication Details
- Journal
- Leukemia & lymphoma/Leukemia and lymphoma
- Published
- 2026-09-06
- DOI
- https://doi.org/10.1080/10428194.2026.2723846
- Primary Topic
- Cell death mechanisms and regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- CLL Global Research Foundation